• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients.

作者信息

Ball A P, Fox C, Ball M E, Brown I R, Willis J V

出版信息

J Antimicrob Chemother. 1986 May;17(5):629-35. doi: 10.1093/jac/17.5.629.

DOI:10.1093/jac/17.5.629
PMID:2941402
Abstract

The pharmacokinetics of ciprofloxacin following a single 100 mg oral dose were evaluated in elderly patients (mean age 74 years), laboratory staff (30-40 years) and students (less than 20 years). There were no significant differences in serum Tmax (1.2-1.3 h) or in overall serum elimination half-life (3.7-4.0 h) but Cmax in elderly patients was more than double that in young volunteers (P less than 0.005). The serum AUC value was greater both in fasting students (1.4 mg/h/l) compared with the same subjects after food (1.09: P less than 0.01) and, after food, in elderly patients (1.95) compared with students (0.81: P less than 0.005). Urinary recoveries were greater in fasting subjects and in all categories of volunteers compared with elderly patients. However, in the elderly, urinary ciprofloxacin concentrations (0-6 h mean 66 mg/l: range 17.4-200 mg/l) were more than adequate for the eradication of urinary pathogens.

摘要

相似文献

1
Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients.
J Antimicrob Chemother. 1986 May;17(5):629-35. doi: 10.1093/jac/17.5.629.
2
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.口服和静脉注射后环丙沙星在健康志愿者体内的药代动力学。
Eur J Clin Microbiol. 1986 Apr;5(2):179-86. doi: 10.1007/BF02013983.
3
Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
Eur J Clin Microbiol. 1986 Apr;5(2):187-92. doi: 10.1007/BF02013984.
4
Ciprofloxacin pharmacokinetics in patients with cystic fibrosis.
Infection. 1986 Jan-Feb;14(1):17-21. doi: 10.1007/BF01644804.
5
Pharmacokinetics of ciprofloxacin in elderly subjects.
Pharmacotherapy. 1986 Mar-Apr;6(2):87-91. doi: 10.1002/j.1875-9114.1986.tb03458.x.
6
Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis.囊性纤维化患者口服环丙沙星的单剂量药代动力学
J Clin Pharmacol. 1986 Mar;26(3):222-6. doi: 10.1002/j.1552-4604.1986.tb02938.x.
7
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.标准早餐对环丙沙星药物吸收及多剂量药代动力学的影响。
Antimicrob Agents Chemother. 1985 Mar;27(3):350-2. doi: 10.1128/AAC.27.3.350.
8
Single and multiple dose pharmacokinetics of ciprofloxacin.
Eur J Clin Microbiol. 1986 Apr;5(2):193-6. doi: 10.1007/BF02013985.
9
Multiple-dose ciprofloxacin dose ranging and kinetics.
Clin Pharmacol Ther. 1985 Jun;37(6):633-7. doi: 10.1038/clpt.1985.102.
10
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.

引用本文的文献

1
Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses.联合或分开?揭示饮食干预对喹诺酮类药物生物利用度的影响:系统评价与荟萃分析。
Clin Pharmacokinet. 2024 Jun;63(6):773-818. doi: 10.1007/s40262-024-01377-0. Epub 2024 May 28.
2
Pharmacokinetic considerations in the treatment of inflammatory bowel disease.炎症性肠病治疗中的药代动力学考量
Clin Pharmacokinet. 2001;40(10):723-51. doi: 10.2165/00003088-200140100-00003.
3
Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
两种新型氟喹诺酮类药物巴洛沙星和格帕沙星在老年受试者体内的药代动力学比较研究。
Antimicrob Agents Chemother. 1996 Dec;40(12):2824-8. doi: 10.1128/AAC.40.12.2824.
4
Quinolones in the elderly.老年人中的喹诺酮类药物
Drugs. 1995;49 Suppl 2:112-4. doi: 10.2165/00003495-199500492-00017.
5
Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly.环丙沙星:老年患者药理学特征及治疗应用综述
Drugs Aging. 1994 Feb;4(2):145-73. doi: 10.2165/00002512-199404020-00007.
6
Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects.高剂量静脉注射环丙沙星在青年、老年以及男性和女性受试者中的药代动力学。
Antimicrob Agents Chemother. 1995 Apr;39(4):1003-6. doi: 10.1128/AAC.39.4.1003.
7
Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.抗酸剂和透析液驻留时间对持续非卧床腹膜透析患者口服环丙沙星多剂量药代动力学的影响。
Antimicrob Agents Chemother. 1987 Nov;31(11):1787-90. doi: 10.1128/AAC.31.11.1787.
8
Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.环丙沙星与亚胺培南-西司他丁治疗严重临床感染的前瞻性随机对照研究。
Antimicrob Agents Chemother. 1987 Oct;31(10):1491-6. doi: 10.1128/AAC.31.10.1491.
9
Antibiotic therapy in aging patients.老年患者的抗生素治疗
Bull N Y Acad Med. 1987 Jul-Aug;63(6):519-32.
10
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.